Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
5.52
+0.03 (0.55%)
May 12, 2025, 4:00 PM - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $87.98 million as of May 12, 2025. Its market cap has decreased by -6.94% in one year.
Market Cap
87.98M
Enterprise Value
96.41M
1-Year Change
-6.94%
Ranking
Category
Stock Price
$5.52
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $87.98M, a decrease of -71.82%. That is a compound annual growth rate of -48.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 87.51M | 59.21% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |